AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glyzula M 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Nivulia Lifesciences Private Limited

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glyzula M 80mg/500mg Tablet

Metformin/Gliclazide 80mg/500mg tablets are classified as antidiabetic medications. This dual-drug formulation manages type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled glucose levels; abrupt cessation can lead to hyperglycemia and potentially serious complications like nephropathy, retinopathy, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Common adverse effects include hypoglycemia (low blood sugar), characterized by symptoms such as sweating, dizziness, headache, and tremors; constipation; and nausea. Prompt glucose intake (e.g., sugary foods, fruit juice) is vital to manage hypoglycemic episodes. Regular meals are essential, and carrying a rapid-acting glucose source is recommended. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste perception, diarrhea, abdominal discomfort, cephalalgia, upper respiratory infections, and weight gain. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or significant hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before initiating treatment. Consult your doctor before using this medication if you are pregnant or breastfeeding. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glyzula M 80mg/500mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Glyzula M 80mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Glyzula M 80mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glyzula M 80mg/500mg Tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.

Common Side effects of Glyzula M 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glyzula M 80mg/500mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Glyzula M 80mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

How Glyzula M 80mg/500mg Tablet works:

Each Glyzula M 80mg/500mg tablet combines the antidiabetic agents gliclazide and metformin.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol while taking Glyzula M 80mg/500mg tablets.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glyzula M 80mg/500mg tablets during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in exceptional, life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glyzula M 80mg/500mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Impaired driving is a potential consequence of both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glyzula M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Glyzula M 80mg/500mg tablet use. Physician consultation is necessary. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glyzula M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate hepatic dysfunction, initiation should be at a reduced dose; the medication is contraindicated in patients with severe liver disease.

What if you forget to take Glyzula M 80mg/500mg Tablet :

Should you forget to take a Glyzula M 80mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glyzula M 80mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Glyzula M 80mg/500mg Tablet

Glyzula M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus (DM) in adults. This treatment improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glyzula M is unsuitable for type 1 DM.
Glyzula M 80mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glyzula M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Glyzula M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect is less likely in patients without kidney disease, those who aren't elderly, and those who don't consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glyzula M 80mg/500mg Tablets and seek immediate medical attention.
Prolonged use of Glyzula M 80mg/500mg tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, supplemental vitamin B12 intake is recommended at least annually, according to some research.
Glyzula M 80mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Glyzula M 80mg/500mg tablets with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Glyzula M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glyzula M 80mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glyzula M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Glyzula M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This is a rare side effect, but the risk increases in patients with kidney disease, older adults, and those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glyzula M 80mg/500mg Tablets and seek immediate medical attention.
Yes, prolonged Glyzula M 80mg/500mg Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems—ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glyzula M 80mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate-to-severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Consuming alcohol while taking Glyzula M 80mg/500mg tablets is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Glyzula M 80mg/500mg Tabl...
65
MRP 79
17% off